Fusion Genomics

Fusion Genomics is a molecular diagnostics company developing ONETest™, an in-hospital targeted metagenomic platform designed to close diagnostic gaps in life-threatening infections. The company combines targeted metagenomics, automation, and FusionCloud™ Actionable Intelligence to help hospital laboratories turn complex microbial sequence data into clinically interpretable results. Its ONETest™ reagents and software are supplied for research use only and are not intended for diagnostic or therapeutic use; any clinical use requires independent validation by an appropriately accredited clinical laboratory.

Fusion Genomics was founded by scientists and engineers with deep experience translating complex genomic data into practical applications. The company develops technologies for hospital-based genomic diagnostics, with availability and use subject to applicable laboratory validation and regulatory requirements.

Advancing metagenomics for hospital labs; designed to support broad, efficient targeted metagenomic workflows in accredited laboratory settings.

• ONETest™

  An in-hospital targeted metagenomic platform powered by QuantumProbes™ that enriches targeted microorganism genomic signal while preserving a representative view of the microbial community. It covers 50 families and 300+ clinically relevant organisms.

• FusionCloud™

  AI-driven analytics providing 'Actionable Intelligence' for relevance, resistance, and causation support.

• QuantumProbes™

  Core-genome capture enrichment technology spanning bacteria, fungi, and DNA viruses.

1. 1Fusion Genomics | ONETest™ Targeted Metagenomics for Hospital Labsfusiongenomics.com
2. 2About Us | Fusion Genomicsfusiongenomics.com